CS logo
small CS logo
Hospital Nossa Senhora das Gracas

Curitiba, Brazil
Hospital in Curitiba, State of Paraná
R. Alcídes Munhoz, 433 - Mercês, Curitiba - PR, 80810-040

About Hospital Nossa Senhora das Gracas


"Hospital Geral de alta complexidade e referência em transplante de medula óssea."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
5
Eurofarma Laboratorios S.A.
2
Janssen Research & Development, LLC
2
Pfizer
2
Astellas Pharma Inc
1
AstraZeneca
1
Gilead Sciences
1
Janssen Vaccines & Prevention B.V.
1
Otsuka Pharmaceutical Development & Commercialization, Inc.
1
Terumo Europe N.V.
1
Total Rows: 10

Clinical Trials at Hospital Nossa Senhora das Gracas


During the past decade, Hospital Nossa Senhora das Gracas conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 5 clinical trials were completed, i.e. on average, 62.5% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years2200224400000000Started TrialsCompleted Trails20182019202020210246
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
EVEREST: Efficacy of Vasopressin Antagonism in hEart failuRE: Outcome Study With Tolvaptan
2003-09-01
2006-07-01
Completed
3,600
Effect of AC2993 Compared With Insulin Glargine in Patients With Type 2 Diabetes Also Using Combination Therapy With Sulfonylurea and Metformin
2003-06-01
2008-07-01
Completed
551
Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections
2007-03-08
2015-03-03
Completed
450
A Non-inferiority, Multicenter and Randomized, Single-Dose Study About a Treatment to Hypolactasia (LAILAI)
2011-07-01
2012-03-01
Completed
140
A Non-inferiority, Multicenter and Randomized, Multiple-Dose Study About a Treatment to Hypolactasia
2011-06-01
2012-05-01
Completed
140
e-NOBORI Observational Registry of Nobori DES
2010-08-25
2016-05-27
Completed
18,000
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
2011-02-01
2015-02-01
Completed
250
B0151005 Open-Label Extension Study
2011-06-01
2016-03-01
Completed
191

Rows per page:

1–17 of 17

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Hospital Nossa Senhora das Gracas" #1 sponsor was "Hoffmann-La Roche" with 5 trials, followed by "Eurofarma Laboratorios S.A." with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Astellas Pharma Inc" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Nossa Senhora das Gracas" #1 collaborator was "Atea Pharmaceuticals, Inc." with 2 trials as a collaborator, "Basilea Pharmaceutica" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Gilead Sciences" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.
Created with Highcharts 11.1.0Top Leading SponsorsHoffmann-La Roche: 5Hoffmann-La Roche: 5Eurofarma Laboratorios S.A.: 2Eurofarma Laboratorios S.A.: 2Janssen Research &Development, LLC: 2Janssen Research &Development, LLC: 2Pfizer: 2Pfizer: 2Astellas Pharma Inc: 1Astellas Pharma Inc: 1AstraZeneca: 1AstraZeneca: 1Gilead Sciences: 1Gilead Sciences: 1Janssen Vaccines &Prevention B.V.: 1Janssen Vaccines &Prevention B.V.: 1Otsuka PharmaceuticalDevelopment &Commercialization, Inc.:1Otsuka PharmaceuticalDevelopment &Commercialization, Inc.:1Terumo Europe N.V.: 1Terumo Europe N.V.: 1

Created with Highcharts 11.1.0Top CollaboratorsAtea Pharmaceuticals, Inc.: 2Atea Pharmaceuticals, Inc.: 2Basilea Pharmaceutica: 1Basilea Pharmaceutica: 1Eli Lilly and Company: 1Eli Lilly and Company: 1Gilead Sciences: 1Gilead Sciences: 1

Clinical Trials Conditions at Hospital Nossa Senhora das Gracas


According to Clinical.Site data, the most researched conditions in "Hospital Nossa Senhora das Gracas" are "COVID-19" (3 trials), "Crohn's Disease" (3 trials), "Alzheimer Disease" (2 trials), "COVID-19 Pneumonia" (1 trials) and "Candidemia" (1 trials). Many other conditions were trialed in "Hospital Nossa Senhora das Gracas" in a lesser frequency.

Clinical Trials Intervention Types at Hospital Nossa Senhora das Gracas


Most popular intervention types in "Hospital Nossa Senhora das Gracas" are "Drug" (13 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Gantenerumab" (2 trials), "Remdesivir" (2 trials), "Ustekinumab" (2 trials) and "Ad26.COV2.S" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Hospital Nossa Senhora das Gracas


The vast majority of trials in "Hospital Nossa Senhora das Gracas" are 17 trials for "All" genders.

Clinical Trials Status at Hospital Nossa Senhora das Gracas


Currently, there are NaN active trials in "Hospital Nossa Senhora das Gracas". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Hospital Nossa Senhora das Gracas, undefined suspended trials, and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Hospital Nossa Senhora das Gracas, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 12Phase 3: 12Phase 2: 3Phase 2: 3

Created with Highcharts 11.1.0Trials StatusCompleted: 10Completed: 10Terminated: 4Terminated: 4Active, not recruiting: 2Active, not recruiting: 2No longer available: 1No longer available: 1